Adaptation of the protein misfolding cyclic amplification (PMCA) technique for the screening of anti‐prion compounds
- 28 July 2024
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 38 (14) , e23843
Abstract
Prion diseases result from the misfolding of the physiological prion protein (PrP C ) to a pathogenic conformation (PrP Sc ). Compelling evidence indicates that prevention and/or reduction of PrP Sc replication are promising therapeutic strategies against prion diseases. However, the existence of different PrP Sc conformations (or strains) associated with disease represents a major problem when identifying anti‐prion compounds. Efforts to identify strain‐specific anti‐prion molecules are limited by the lack of biologically relevant high‐throughput screening platforms to interrogate compound libraries. Here, we describe adaptations to the protein misfolding cyclic amplification (PMCA) technology (able to faithfully replicate PrP Sc strains) that increase its throughput to facilitate the screening of anti‐prion molecules. The optimized PMCA platform includes a reduction in sample and reagents, as well as incubation/sonication cycles required to efficiently replicate and detect rodent‐adapted and cervid PrP Sc strains. The visualization of PMCA products was performed via dot blots, a method that contributed to reduced processing times. These technical changes allowed us to evaluate small molecules with previously reported anti‐prion activity. This proof‐of‐principle screening was evaluated for six rodent‐adapted prion strains. Our data show that these compounds targeted either none, all or some PrP Sc strains at variable concentrations, demonstrating that this PMCA system is suitable to test compound libraries for putative anti‐prion molecules targeting specific PrP Sc strains. Further analyses of a small compound library against deer prions demonstrate the potential of this new PMCA format to identify strain‐specific anti‐prion molecules. The data presented here demonstrate the use of the PMCA technique in the selection of prion strain‐specific anti‐prion compounds.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01AI132695, P01AI077774)
- Creutzfeldt-Jakob Disease Foundation
This publication has 78 references indexed in Scilit:
- Emergence of CWD strainsCell and tissue research, 2022
- Transmission of cervid prions to humanized mice demonstrates the zoonotic potential of CWDActa Neuropathologica, 2022
- Therapeutic strategies for identifying small molecules against prion diseasesCell and tissue research, 2022
- A Small‐Molecule Inhibitor of Prion Replication and Mutant Prion Protein ToxicityChemMedChem, 2017
- Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal FluidJAMA Neurology, 2017
- Chronic Wasting Disease2011
- Chemically Induced Accumulation of GAGs Delays PrPSc Clearance but Prolongs Prion Disease Incubation TimeCellular and Molecular Neurobiology, 2008
- Rhodanine‐Based Tau Aggregation Inhibitors in Cell Models of TauopathyAngewandte Chemie International Edition, 2007
- Chronic Wasting Disease of Cervids2004
- Transmissible Spongiform EncephalopathiesBiochemical and Biophysical Research Communications, 1998